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Some scientists have tentatively 
proposed to name the virus bovine vi-
ral diarrhea 3, but others believe this 
nomenclature would be problematic 
from regulatory and scientifi c stand-
points (J. Ridpath, pers. comm.). 
Molecular assays standardized for 
BVDV-1/2 might not be able to detect 
‘Hobi’-like strains because of the pres-
ence of mismatches in the oligonucle-
otide binding regions (7). Prophylactic 
measures should take into account the 
circulation of ‘Hobi’-like pestiviruses 
in cattle herds. Whether commercial 
BVDV vaccines are effective against 
the emerging pestivirus is unknown, 
and requires future in vivo cross-pro-
tection studies.
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Bartonella spp. 
Bacteremia and 
Rheumatic 
Symptoms in 
Patients from Lyme 
Disease–endemic 
Region
To the Editor: We believe the 
recent article by Maggi et al. (1) con-
tains serious fl aws in content and un-
derlying message, including a poorly 
defi ned study population, lack of ap-
propriate controls, improper use of 
the term bacteremia, and incongruent 
laboratory fi ndings. Selection criteria 
were vague: the authors state only that 
participants were a “biased” collection 
of “patients selected by a rheumatolo-
gist,” with no control population in-
cluded for comparison. The diagnosis 
of Lyme disease and other previously 
diagnosed conditions was solely by 
self-report. Although blood samples 
were collected from every participant, 
the authors apparently neglected to 
perform standardized testing for Bor-
relia burgdorferi or other conditions.
The term “bacteremia” signi-
fi es presence of viable bacteria in the 
bloodstream, which is not substanti-
ated solely by a positive PCR result. 
True bacteremia was documented in 
only 1.7% of participants from whom 
a viable Bartonella species isolate was 
cultured, rather than the purported 
41.1% of participants.
Surprisingly, many participants 
whose PCR results were positive 
for Bartonella spp. had no serologic 
evidence of infection (e.g., 82.5% of 
samples that had positive PCR re-
sults for Bartonella henselae were 
not seroreactive). Although anergy 
has been reported, samples from 
most immunocompetent and immu-
nocompromised patients infected 
with Bartonella spp. are seroreac-
tive (2–4), calling into question the 
authors’ fi ndings. Furthermore, 24% 
of samples that were positive by PCR 
revealed no identifi able Bartonella 
spp. by DNA sequencing; these par-
ticipants should have been excluded 
from analysis.
Maggi et al. hypothesize that Bar-
tonella spp. infection is causally relat-
ed to a variety of chronic ailments. In 
fact, there was no association within 
the study population between posi-
tive Bartonella spp. PCR results and 
chronic illness, self-reported Lyme 
disease, or even a prior diagnosis of 
bartonellosis.
Efforts to defi ne the clinical and 
public health importance of Barton-
ella spp. require scientifi c rigor. The 
above issues challenge the validity of 
the study, and results should be inter-
preted with caution.
C. Ben Beard, 
Christina A. Nelson, 
Paul S. Mead, 
and Lyle R. Petersen
Author affi liation:  Centers for Disease Con-
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To the Editor: Some chronic 
diseases, including multiple sclerosis, 
chronic arthritis (1), cognitive 
disorders, and chronic fatigue remain 
unexplained, yet patients and patient 
advocacy groups are anxious to fi nd an 
explanation and a cure. For 50 years, 
zoonotic agents have been wrongly 
considered as the cause of many of 
these diseases because diagnoses 
were based on results of serologic 
tests with low specifi city. In France, at 
the beginning of my career, serologic 
testing for rickettsia was used as a 
diagnostic tool for many of these 
diseases and prompted inappropriate 
antimicrobial drug use because 
micro-agglutination on a slide is a 
nonspecifi c serologic technique (2). I 
had a hard time reversing this practice.
Results of serologic testing for 
nanobacteria were also unconfi rmed 
because they were based on 
nonspecifi c antibodies (3). Results of 
Lyme disease serologic tests lacking 
specifi city were also associated with 
these chronic diseases and led to the 
same results and confl icts between 
the Infectious Diseases Society of 
America and alternative users of 
Borrelia burgdorferi diagnostic tests 
(4). Currently, Google search pages 
display more results for alternative 
interpretations than for scientifi c 
information. Again, I have tried to 
limit the damages in France without 
success (5).
Now the Bartonella spp. appear 
as the new candidates to explain 
chronic illness (1). Once more, I am 
confronted with the problem in France. 
Some patients whose test results are 
negative in my laboratory were tested 
at the College of Veterinary Medicine, 
North Carolina State University, 
Raleigh, NC, USA (3) and received 
positive results (using a technique that 
I have not been able to reproduce). 
Now one of my patients is arguing and 
menacing because I do not confi rm his 
infection by Bartonella spp.
We need to follow rigorous 
standards of causal infl uence before 
claiming that a bacterium is causing 
an unexplained chronic disease, to 
avoid facing the same problem that we 
had with Lyme disease: a mess with 
open confl icts between most scientists 
and some atypical investigators and 
patient advocacy groups.
Didier Raoult
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In Response: We offer the fol-
lowing comments to Beard et al. (1) 
and Raoult (2) regarding their respec-
tive responses to our recent article 
(3). Before 1990, Bartonella species 
were not known to infect animals or 
humans in North America. If not for 
the AIDS epidemic, the expansion of 
literature about Bartonella spp. might 
not have occurred (Figure). In 2010, 
in collaboration with Raoult (4), we 
posed a question in Emerging Infec-
tious Diseases, “Could ticks transmit 
Bartonella spp.?” That article elicited 
an editorial response emphasizing the 
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lack of evidence supporting tick trans-
mission of Bartonella spp. (5). Sub-
sequently, Bartonella birtlesii trans-
mission by Ixodes ricinus ticks was 
proven experimentally (6).
We now hope that this article will 
stimulate others to investigate a poten-
tial role for Bartonella spp. in rheu-
matologic diseases. Whether caused 
by politics or priorities, over the past 
22 years, National Institutes of Health 
funding for Bartonella spp. research 
has been minimal and the US Centers 
for Disease Control and Prevention 
(CDC) has not critically investigated 
the medical impact of this genus of 
bacteria in US citizens. On 2 occa-
sions, researchers at CDC declined 
to examine serum from these patients 
for antibodies against Borrelia burg-
dorferi. Because our research was not 
funded by any governmental agency, 
testing beyond our focus was not fi -
nancially feasible.
We do not agree with the asser-
tion that our study “contains seri-
ous fl aws in content and underlying 
message, including a poorly defi ned 
study population, lack of appropri-
ate controls, improper use of the term 
bacteremia, and incongruent labora-
tory fi ndings.” As indicated in the 
Materials and Methods section of our 
article, a physician, B. Robert Mozay-
eni, recipient of a Yale residency and 
rheumatology fellowship and predoc-
toral and postdoctoral molecular im-
munology fellowships at the National 
Institutes of Health, selected all study 
participants. In this exploratory cross-
sectional study, entry criteria were not 
rigid and controls were not selected 
at patient recruitment but were de-
fi ned later from the study population. 
Strikingly, serologic and molecular 
prevalence was higher among selected 
patients than among occupationally 
high-risk veterinary professionals (7) 
tested in the same laboratory by us-
ing the same diagnostic techniques. In 
our article, associations were reported, 
causation was not argued, and caution 
in results interpretation was addressed 
in the discussion.
Bacteremia is defi ned as the pres-
ence of bacteria in the blood. To sug-
gest that agar plate isolation is the 
only way to document bacteremia is 
inappropriate. B. burgdoferi does not 
grow on an agar plate, and its isola-
tion was challenging before develop-
ment of insect-based liquid growth 
media. PCR testing is routinely used 
in human and veterinary medicine to 
diagnose bacteremic infections by 
Anaplasma, Ehrlichia, hemotrophic 
Mycoplasma, and Rickettsia spp. For 
example, Ehrlichia ewingii, a recog-
nized pathogen of canids and humans, 
has never been successfully isolated, 
whereas bacteremia is routinely diag-
nosed by using PCR.
In the spirit of collaboration, we 
have distributed Bartonella α Proteo-
bacteria growth medium, an insect 
cell culture-based growth medium 
developed at and patented by North 
Carolina State University, to research-
ers around the world. Recipients in-
cluded Michael Kosoy at CDC, who 
subsequently used this medium to 
isolate Candidatus Bartonella tamiae 
from febrile patients in Thailand (8). 
Subsequent studies have validated 
insect cell culture-based media for 
growth of Bartonella spp. For reasons 
that remain less than clear, there is 
incongruence between results of se-
rologic testing and results of enrich-
ment blood culture and PCR, which 
was addressed in our discussion and 
previous publications (7). In contrast 
to reports of the lack of antibodies in 
some bacteremic patients, we have 
reported specifi c serologic responses 
to infecting Bartonella spp. (9,10). 
The dated references provided by the 
correspondents relative to serologic 
testing do not address our bacteremic 
study population or their diseases.
We agree with Raoult that sensi-
tive and specifi c diagnostic tests are 
critically needed to defi ne the patho-
physiology of bartonellosis. We also 
agree that bartonellosis is not bor-
reliosis, and the 2 diseases should not 
be confused by patients, advocacy 
groups, Lyme disease researchers, or 
governmental agencies.
Ricardo G. Maggi,  
B. Robert Mozayeni, 
Elizabeth L. Pultorak, 
Barbara C. Hegarty, 
Julie M. Bradley, Maria Correa, 
and Edward B. Breitschwerdt
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Figure. Annual worldwide number of published articles about Bartonella spp., 1990–2011. 
Data source: www.pubmed.gov.
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